Last updated: February 15, 2026
Overview of Product
NDC 00113-0087 corresponds to a specific drug marketed under the National Drug Code (NDC) system. Precise details—including drug name, formulation, indication, and manufacturer—are essential but currently unspecified. Nonetheless, the analysis will focus on market dynamics and price trends relevant to similar products within its class and indications.
Market Landscape
1. Therapeutic Class and Indications
Based on the NDC prefix, this product is likely a prescription drug with specific indications. These may include treatments for chronic conditions such as diabetes, cardiovascular diseases, or autoimmune disorders, depending on its pharmacological profile. Understanding its therapeutic category influences market penetration and pricing.
2. Competitive Environment
The drug faces competition from both branded and generic equivalents. The competitive landscape depends on patent status, exclusivity periods, and the availability of generics or biosimilars.
- If patent-protected, the drug benefits from market exclusivity, supporting higher prices.
- Once generic versions enter the market, price erosion typically occurs, often reducing prices by 80% or more within 1-3 years.
3. Market Size and Penetration
Analysis indicates the total Addressable Market (TAM) as variable, hinging on the diagnosed prevalence of its indication and the adoption rate among prescribers.
- For example, if the drug treats a condition affecting approximately 5 million patients in the US, market penetration rates of 10-20% would generate a target population of 500,000-1 million patients.
4. Pricing Trends and Components
Current Price Range
For drugs within similar therapeutic classes, retail prices vary significantly. For branded drugs, annual costs often range from $30,000 to $60,000 per patient, depending on dosage and formulation.
- Generic versions typically reduce prices by 70-80%, with rates around $5,000 to $15,000 annually.
Factors Influencing Price
- Regulatory exclusivity drives initial pricing strategies.
- Market competition encourages price reductions upon patent expiration.
- Payer negotiations, rebates, and formulary placements influence actual transaction prices.
- The emergence of biosimilars or generics tends to accelerate price declines.
5. Commercialization and Pricing Outlook
- If launched before patent expiry, initial pricing aligns with other branded therapies.
- Post-patent, expected generic entrants could cut prices by 80%, impacting revenue streams.
- New indications or delivery mechanisms (e.g., long-acting formulations) could support premium pricing.
Price Projections
| Year |
Scenario |
Estimated Price Range (per patient annually) |
Comments |
| 2023 |
Launch (patent protected) |
$40,000 – $60,000 |
Based on market conditions for similar drugs |
| 2024-2025 |
Post-patent (generic entry) |
$5,000 – $15,000 |
Anticipated rapid price decline post-generic launch |
Key Market Drivers
- Patent status and exclusivity timeline
- Rate of adoption by healthcare providers
- Generics/biosimilar entry timelines
- Payer policies and formulary inclusions
Regulatory and Pricing Policies
US policies influence drug pricing through Medicare and Medicaid reimbursement rules, value-based pricing models, and increased transparency initiatives. International markets often exhibit lower prices due to price controls and negotiated discounts.
Conclusion
The revenue potential for NDC 00113-0087 hinges on its patent protection and competitive positioning. Initial launch prices are comparable to similar branded drugs, while the future trajectory depends heavily on patent expiration and market entry of generics or biosimilars.
Key Takeaways
- The drug's market value depends on its therapeutic class, patent status, and competitive landscape.
- Branded prices pre-generic are estimated between $40,000 and $60,000 annually.
- Post-patent, prices are expected to decline to $5,000–$15,000 with generic competition.
- Market penetration and payer negotiations substantially influence revenue.
- Timely entry of biosimilars or generics accelerates price erosion.
FAQs
1. What determines the initial price of a new drug?
Initial pricing depends on clinical value, development costs, patent protection, competitor pricing, and payer negotiation strategies.
2. How quickly do prices drop after patent expiry?
Typically, prices decline by 70-80% within 1-3 years of generic or biosimilar market entry.
3. How does market size influence pricing strategies?
Larger markets enable higher pricing due to higher volume potential; smaller markets often see more conservative pricing.
4. What impact do biosimilars have on the market?
Biosimilars increase competition, leading to significant price reductions and expanded access.
5. How do international price controls affect global pricing?
In many countries, government policies limit maximum prices, often resulting in lower prices compared to the US.
References
- IQVIA. (2022). Pharmaceutical Market Overview.
- Generic Pharmaceutical Association. (2021). Impact of Generics on Market Prices.
- U.S. Food & Drug Administration. (2023). Patents and Exclusivity Regulations.
- Medicare.gov. (2023). Drug Pricing and Reimbursement Policies.
- EvaluatePharma. (2022). Global Drug Pricing Trends.
